MYCN and rhabdomyosarcoma: Embryonal tumors with MYCN deregulation such as neuroblastoma, retinoblastoma, medulloblastoma, Wilms tumor, and rhabdomyosarcoma are highly malignant and are often less amenable to targeted therapies.